News Sanofi, Regeneron’s wager on Dupixent in COPD pays off Approval in COPD could unlock a $3 billion market opportunity for the drug, say analysts.
News 89bio shows its NASH hand, boosting FGF21 concept Positive phase 2b results on liver fibrosis follow similar data with a rival drug from Akero.
News Novartis pulls plug on landmark UK cholesterol trial ORION-17 study has been abandoned, with Novartis opting instead for a smaller global trial.
News Astellas GLOWing as Claudin drug aces gastric cancer trial Pair of positive phase 3 studies means company will file for approval of zolbetuximab soon.
News Roche, Lilly join forces on blood test for Alzheimer’s If approved, EAPP could help streamline the journey to diagnosis for patients, say partners.
News Japanese pharmas sign up to use new AI supercomputer Mitsui, NVIDIA's Tokyo-1 supercomputer, aims to turbocharge Japan’s use of AI in drug discovery
News NICE backs UCB drug as first uncontrolled gMG therapy UCB's Rystiggo can be used by the NHS as a backup treatment for people with the rare autoimmune and neuromuscular disease gMG, says NICE.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
